A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802

Sarcomatoid features can arise in renal cell carcinoma of any subtype and are associated with a poor prognosis. Doxorubicin and gemcitabine in a limited series showed activity in aggressive renal tumors and we wished to formally assess the combination in patients with renal cell carcinoma specifical...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Haas, Naomi B., Lin, Xinyi, Manola, Judith, Pins, Michael, Liu, Glenn, McDermott, David, Nanus, David, Heath, Elisabeth, Wilding, George, Dutcher, Janice
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2011
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3566570/
https://ncbi.nlm.nih.gov/pubmed/21298497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-011-9829-8
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk